Jupiter Neurosciences Inc (JUNS)

$0.10 +0.01 (11.11%)
Market Cap 3.27M
Revenue (ttm) 20,000.00
Net Income (ttm) -8.64M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -43,200.00%
Debt to Equity Ratio 0.00
Volume 12,627,000
Avg Vol 12,936,430
Day's Range N/A - N/A
Shares Out 36.28M
Stochastic %K 14%
Beta 1.73
Analysts Strong Buy
Price Target $25.00

Company Profile

Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company, engages in the development of therapeutics for central nervous system disorders and rare diseases in the United States and internationally. It operates in two segments, Pharmaceutical Operations and Premium Nutritional Supplements. The company researches and develops JNS115, which is in Phase IIa clinical trial for the treatment of Parkinson's disease; JNS108, which is in Phase II clinical trial for th...

Industry: Biotechnology
Sector: Healthcare
Phone: 561 406 6154
Address:
1001 North US Highway 1, Suite 504 Palm Beach Gardens, Jupiter, United States
Rampart1
Rampart1 Aug. 3 at 11:11 PM
$JUNS something up here. ww.
0 · Reply
i_like_bb_stock
i_like_bb_stock Aug. 3 at 9:47 PM
$JUNS took some one of only a few down here just needs volume to do what $RITR and $MGN did today
0 · Reply
Riddertopia
Riddertopia Aug. 3 at 4:19 PM
$JUNS lets see .13 here
0 · Reply
Rampart1
Rampart1 Aug. 3 at 4:06 PM
$JUNS on the move here.
0 · Reply
FeliciaMath
FeliciaMath Aug. 1 at 11:04 PM
$JUNS whoever bought this stock after it went to .28 on 7/21 major bagholder. .09 now.
0 · Reply
BlazeofFury
BlazeofFury Aug. 1 at 4:53 PM
Keep a close watch on RUBI ✅️ 🔥Big news: 600k float. -"Rubico Inc. (NASDAQ: RUBI) recently announced the acquisition of its third newbuilding MR tanker, a 94% surge in its net asset value,raising potential gross revenue backlog to roughly $379 million." Got paid on $ELPW $KWM $JUNS next up RUBI!
0 · Reply
lrndhfjcj
lrndhfjcj Jul. 31 at 10:03 PM
$JUNS purely scam just did fake 1 mil deal lolo RS on the table anytime comes📉💩
0 · Reply
Perlaksen
Perlaksen Jul. 31 at 5:27 PM
$JUNS move on very little volume. This can go crazy when real volume kick in $TGHL $COSM $GCTK
0 · Reply
Perlaksen
Perlaksen Jul. 31 at 4:38 PM
$JUNS
0 · Reply
Woodyp123
Woodyp123 Jul. 31 at 4:13 PM
$JUNS are they going to do a RS in near future?
1 · Reply
Latest News on JUNS
Psychedelic: PharmAla enters license agreement with Jupiter Neurosciences

2026-07-23T15:10:37.000Z - 11 days ago

Psychedelic: PharmAla enters license agreement with Jupiter Neurosciences

ATAI CMND GHRS HELP LLY NRXP

Jupiter Neurosciences Stock (JUNS) Jumps on a New License Deal

2026-07-21T18:19:53.000Z - 13 days ago

Jupiter Neurosciences Stock (JUNS) Jumps on a New License Deal

PharmAla enters up to $100M ALA-002 license pact with Jupiter Neurosciences

2026-07-21T11:15:16.000Z - 13 days ago

PharmAla enters up to $100M ALA-002 license pact with Jupiter Neurosciences

Jupiter Neurosciences (NASDAQ: JUNS) Signs Definitive Agreement for Exclusive U.S. Rights to ALA-002 in Transaction Valued at Up to $100 Million

Jul 21, 2026, 7:13 AM EDT - 13 days ago

Jupiter Neurosciences (NASDAQ: JUNS) Signs Definitive Agreement for Exclusive U.S. Rights to ALA-002 in Transaction Valued at Up to $100 Million

Jupiter Neurosciences Strengthens Board with Appointment of Dr. Tomas J. Philipson

Jul 7, 2026, 8:58 AM EDT - 27 days ago

Jupiter Neurosciences Strengthens Board with Appointment of Dr. Tomas J. Philipson

Jupiter Neurosciences files to sell 16M shares of common stock for holders

2026-06-26T20:35:09.000Z - 5 weeks ago

Jupiter Neurosciences files to sell 16M shares of common stock for holders

Jupiter Neurosciences commences patient enrollment in RESET trial

2026-05-27T12:09:17.000Z - 2 months ago

Jupiter Neurosciences commences patient enrollment in RESET trial

Jupiter Neurosciences Announces Patient Enrollment Underway in Phase 2a RESET Trial in Parkinson's Disease

May 27, 2026, 7:30 AM EDT - 2 months ago

Jupiter Neurosciences Announces Patient Enrollment Underway in Phase 2a RESET Trial in Parkinson's Disease

D. Boral Capital Acted as Exclusive Placement Agent to Jupiter Neurosciences, Inc. (Nasdaq:JUNS) in Connection with its ~$2 Million Registered Direct Offering

May 26, 2026, 12:00 PM EDT - 2 months ago

D. Boral Capital Acted as Exclusive Placement Agent to Jupiter Neurosciences, Inc. (Nasdaq:JUNS) in Connection with its ~$2 Million Registered Direct Offering

Jupiter Neurosciences Announces Closing of $2.0 Million Registered Direct Offering

May 21, 2026, 5:15 PM EDT - 2 months ago

Jupiter Neurosciences Announces Closing of $2.0 Million Registered Direct Offering

Jupiter Neurosciences announces pricing of $2M registered direct offering

2026-05-20T18:40:09.000Z - 2 months ago

Jupiter Neurosciences announces pricing of $2M registered direct offering

Jupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct Offering

May 20, 2026, 2:38 PM EDT - 2 months ago

Jupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct Offering

Jupiter Neurosciences to acquire licensing rights to ALA-002 for $3.33M upfront

2026-05-20T12:17:05.000Z - 2 months ago

Jupiter Neurosciences to acquire licensing rights to ALA-002 for $3.33M upfront

Jupiter Neurosciences Secures $100M Term Sheet for Exclusive U.S. Rights to ALA-002, a Next-Generation MDMA Therapeutic from PharmAla Biotech

May 20, 2026, 7:38 AM EDT - 2 months ago

Jupiter Neurosciences Secures $100M Term Sheet for Exclusive U.S. Rights to ALA-002, a Next-Generation MDMA Therapeutic from PharmAla Biotech

Jupiter Neurosciences, Inc. to Present at The Market Movers Investor Summit

May 4, 2026, 11:30 AM EDT - 3 months ago

Jupiter Neurosciences, Inc. to Present at The Market Movers Investor Summit

Jupiter Neurosciences, Inc. to Present at Centri Capital Conference on April 14

Apr 13, 2026, 8:00 PM EDT - 4 months ago

Jupiter Neurosciences, Inc. to Present at Centri Capital Conference on April 14

Jupiter Neurosciences to present progress at Mar-a-Lago investor dinner

2026-02-25T13:48:57.000Z - 5 months ago

Jupiter Neurosciences to present progress at Mar-a-Lago investor dinner

Jupiter Neurosciences Invited to Present Clinical and Commercial Progress at Investor Dinner at Mar-a-Lago

Feb 25, 2026, 8:30 AM EST - 5 months ago

Jupiter Neurosciences Invited to Present Clinical and Commercial Progress at Investor Dinner at Mar-a-Lago

Jupiter Neurosciences Amends Yorkville Installment Provisions to Align Capital With Clinical and Commercial Execution

Feb 23, 2026, 9:30 AM EST - 5 months ago

Jupiter Neurosciences Amends Yorkville Installment Provisions to Align Capital With Clinical and Commercial Execution

Jupiter Neurosciences expands Nugevia addressable market

2026-01-28T11:30:56.000Z - 6 months ago

Jupiter Neurosciences expands Nugevia addressable market

Jupiter Neurosciences Expands Nugevia™ Addressable Market with Focus on GLP-1 Users

Jan 28, 2026, 6:00 AM EST - 6 months ago

Jupiter Neurosciences Expands Nugevia™ Addressable Market with Focus on GLP-1 Users

Jupiter Neurosciences Presenting at the 3rd Annual DealFlow Discovery Conference

Jan 27, 2026, 10:45 AM EST - 6 months ago

Jupiter Neurosciences Presenting at the 3rd Annual DealFlow Discovery Conference

Join Jupiter Neurosciences' Exclusive Live Investor Webinar and Q&A Session on January 6

Dec 23, 2025, 8:00 AM EST - 7 months ago

Join Jupiter Neurosciences' Exclusive Live Investor Webinar and Q&A Session on January 6

Jupiter Neurosciences to Participate in NobleCon21

Dec 2, 2025, 4:15 PM EST - 8 months ago

Jupiter Neurosciences to Participate in NobleCon21

Jupiter Neurosciences Enters into Agreements for up to $20 Million in Flexible Financing

Oct 27, 2025, 8:30 AM EDT - 10 months ago

Jupiter Neurosciences Enters into Agreements for up to $20 Million in Flexible Financing

Jupiter Neurosciences Names NBA Legend Chris Webber as Second Nugevia™ Brand Ambassador

Aug 19, 2025, 8:12 AM EDT - 1 year ago

Jupiter Neurosciences Names NBA Legend Chris Webber as Second Nugevia™ Brand Ambassador

Jupiter Neurosciences Highlights Critical Advancement of JOTROL™ Over Traditional Resveratrol with Breakthrough Bioavailability and CNS-Targeted Science

Jul 23, 2025, 8:00 AM EDT - 1 year ago

Jupiter Neurosciences Highlights Critical Advancement of JOTROL™ Over Traditional Resveratrol with Breakthrough Bioavailability and CNS-Targeted Science

Jupiter Neurosciences Regains Compliance with Nasdaq Minimum Bid Price Requirement

Jul 10, 2025, 4:05 PM EDT - 1 year ago

Jupiter Neurosciences Regains Compliance with Nasdaq Minimum Bid Price Requirement

Jupiter Neurosciences Showcases Nugevia™ PWR: Mitochondrial Optimization Supplement Designed to Boost Energy, Endurance, and Recovery

Jun 30, 2025, 3:15 PM EDT - 1 year ago

Jupiter Neurosciences Showcases Nugevia™ PWR: Mitochondrial Optimization Supplement Designed to Boost Energy, Endurance, and Recovery

Jupiter Neurosciences Names Golf Legend Annika Sörenstam as First Nugevia™ Brand Ambassador

Jun 23, 2025, 8:00 AM EDT - 1 year ago

Jupiter Neurosciences Names Golf Legend Annika Sörenstam as First Nugevia™ Brand Ambassador

Jupiter Neurosciences Addresses Market Volatility as it Remains Focused on Advancing Clinical and Commercial Milestones

Feb 4, 2025, 9:25 AM EST - 1 year ago

Jupiter Neurosciences Addresses Market Volatility as it Remains Focused on Advancing Clinical and Commercial Milestones

Jupiter Neurosciences Partners with Zina Biopharmaceuticals to Advance Phase 2a Parkinson's Trial

Jan 30, 2025, 8:00 AM EST - 1 year ago

Jupiter Neurosciences Partners with Zina Biopharmaceuticals to Advance Phase 2a Parkinson's Trial

Jupiter Neurosciences, Inc. Announces Closing of $11 million Initial Public Offering

Dec 4, 2024, 4:56 PM EST - 1 year ago

Jupiter Neurosciences, Inc. Announces Closing of $11 million Initial Public Offering

Jupiter Neurosciences, Inc. Announces Pricing of $11 million Initial Public Offering and Listing on Nasdaq

Dec 2, 2024, 7:00 PM EST - 1 year ago

Jupiter Neurosciences, Inc. Announces Pricing of $11 million Initial Public Offering and Listing on Nasdaq

Rampart1
Rampart1 Aug. 3 at 11:11 PM
$JUNS something up here. ww.
0 · Reply
i_like_bb_stock
i_like_bb_stock Aug. 3 at 9:47 PM
$JUNS took some one of only a few down here just needs volume to do what $RITR and $MGN did today
0 · Reply
Riddertopia
Riddertopia Aug. 3 at 4:19 PM
$JUNS lets see .13 here
0 · Reply
Rampart1
Rampart1 Aug. 3 at 4:06 PM
$JUNS on the move here.
0 · Reply
FeliciaMath
FeliciaMath Aug. 1 at 11:04 PM
$JUNS whoever bought this stock after it went to .28 on 7/21 major bagholder. .09 now.
0 · Reply
BlazeofFury
BlazeofFury Aug. 1 at 4:53 PM
Keep a close watch on RUBI ✅️ 🔥Big news: 600k float. -"Rubico Inc. (NASDAQ: RUBI) recently announced the acquisition of its third newbuilding MR tanker, a 94% surge in its net asset value,raising potential gross revenue backlog to roughly $379 million." Got paid on $ELPW $KWM $JUNS next up RUBI!
0 · Reply
lrndhfjcj
lrndhfjcj Jul. 31 at 10:03 PM
$JUNS purely scam just did fake 1 mil deal lolo RS on the table anytime comes📉💩
0 · Reply
Perlaksen
Perlaksen Jul. 31 at 5:27 PM
$JUNS move on very little volume. This can go crazy when real volume kick in $TGHL $COSM $GCTK
0 · Reply
Perlaksen
Perlaksen Jul. 31 at 4:38 PM
$JUNS
0 · Reply
Woodyp123
Woodyp123 Jul. 31 at 4:13 PM
$JUNS are they going to do a RS in near future?
1 · Reply
N0St0pL0ss
N0St0pL0ss Jul. 31 at 2:49 PM
$JUNS Things suck the most right before they blow the hardest. Wait, that came out wrong.
0 · Reply
N0St0pL0ss
N0St0pL0ss Jul. 31 at 2:41 PM
$JUNS
0 · Reply
maxvishphoto
maxvishphoto Jul. 31 at 1:23 PM
$JUNS news ?
1 · Reply
Riddertopia
Riddertopia Jul. 31 at 11:27 AM
$JUNS IDK stuck in this currently. couldn't sell last pop on TOS.
0 · Reply
P_Apez99
P_Apez99 Jul. 31 at 11:20 AM
$JUNS any chance this recovers?
1 · Reply
Perlaksen
Perlaksen Jul. 31 at 10:27 AM
$JUNS
0 · Reply
P_Apez99
P_Apez99 Jul. 31 at 10:23 AM
$JUNS what’s the story here? Can it get back to .15
0 · Reply
Olivia_Strickland
Olivia_Strickland Jul. 31 at 9:39 AM
$JUNS fading 11% premarket to 0.0875 on 15M shares, these sub-penny moves can evaporate fast. watching how it handles the open. anyone else tracking this or am I alone on the scanner on my morning watchlist: https://tapeboard.com/go/st/research/JUNS?utm_source=stocktwits&utm_medium=post&utm_campaign=olivia&utm_content=juns-pm-dn-watch&utm_term=research
0 · Reply
Armazi_Capital
Armazi_Capital Jul. 31 at 9:28 AM
$JUNS should POP here
0 · Reply
Thenew52
Thenew52 Jul. 30 at 6:06 PM
$JUNS How is it possible for a company that isn't even worth that much to get approval for $100 million in stock sales?
1 · Reply
Thenew52
Thenew52 Jul. 30 at 6:05 PM
$JUNS I believed almost blindly in this stock a year ago, but it really turned out to be among the worst; I told you a couple of months ago that there was $100 million worth of stock they could sell—and that it was already approved—so this is simply criminal, and they are taking advantage of retail investors.
0 · Reply
lrndhfjcj
lrndhfjcj Jul. 30 at 5:47 PM
$JUNS dead when dilist ❌
0 · Reply